Register Cart 0

Generic placeholder image

CNS & Neurological Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5273
ISSN (Online): 1996-3181

Back Subscribe

Conference Proceedings

Conference Report: 9th Clinical Trials on Alzheimer's Disease (CTAD): Marriott Marquis San Diego Marina, San Diego, CA, USA December 8-10, 2016

Author(s): Hari S. Sharma*, Stephen D. Skaper and Aruna Sharma

Volume 16, Issue 9, 2017

Page: [1039 - 1042] Pages: 4

DOI: 10.2174/187152731609180119152939

« Previous Next »

Rights & Permissions Print Cite

Article Metrics

37

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

Related Articles

A High-Throughput Screening Assay for Determining Cellular Levels of Total Tau Protein
Current Alzheimer Research

Nutraceuticals in Psychiatric Practice
Recent Patents on CNS Drug Discovery (Discontinued)

A Biomarker Combining Imaging and Neuropsychological Assessment for Tracking Early Alzheimer's Disease in Clinical Trials
Current Alzheimer Research

The Neurobiological Mechanisms and Treatments of REM Sleep Disturbances in Depression
Current Neuropharmacology

Solid Lipid Nanoparticles and Nanostructured Lipid Carriers: A Review
Current Drug Therapy

Renal Biopsy Research with Implications for Therapy of Glomerulonephritis
Current Drug Therapy

Targeted Drug Delivery to Central Nervous System (CNS) for the Treatment of Neurodegenerative Disorders: Trends and Advances
Central Nervous System Agents in Medicinal Chemistry

Acute Management in Very Old Patients: Is Thrombolysis Safe?
Cardiovascular & Hematological Disorders-Drug Targets

Brain Adaptation to Stressful Stimuli: A New Perspective on Potential Therapeutic Approaches Based on BDNF and NMDA Receptors
CNS & Neurological Disorders - Drug Targets

Design of Iodine-Lithium-α-Dextrin Liquid Crystal with Potent Antimicrobial and Anti-Inflammatory Properties
Current Pharmaceutical Design

Weight Loss in Older Persons: New Therapeutic Approaches
Current Pharmaceutical Design

Targeting Stress Activated Protein Kinases, JNK and p38, as New Therapeutic Approach for Neurodegenerative Diseases
Central Nervous System Agents in Medicinal Chemistry

Oxidative Stress, Mitochondrial Dysfunction, and Stress Signaling in Alzheimers Disease
Current Alzheimer Research

Pathogenesis of Alzheimer Disease: Role of Oxidative Stress, Amyloid-β Peptides, Systemic Ammonia and Erythrocyte Energy Metabolism
CNS & Neurological Disorders - Drug Targets

Genetic Polymorphism and Tumor Immunotherapy
Current Pharmacogenomics

The Application of Proteomics in Neurology
Current Proteomics

NAP (Davunetide) Provides Functional and Structural Neuroprotection
Current Pharmaceutical Design

1, 4-Dihydropyridines: A Class of Pharmacologically Important Molecules
Mini-Reviews in Medicinal Chemistry

Thrombomodulin – A New Target for Treating Stroke at the Crossroad of Coagulation and Inflammation
Current Medicinal Chemistry

Impact of Hyperhomocyst(e)inemia on Endothelial Function
Vascular Disease Prevention (Discontinued)

© 2024 Bentham Science Publishers | Privacy Policy